Melioidosis is a disease caused by a bacterium, Burkholderia pseudomallei, and is found across tropical and semi-tropical regions worldwide. An estimated 165,000 people develop melioidosis annually with 89,000 of these cases being fatal.
Melioidosis Vaccine Symposium: "Moving from animal models to man", Feb 2019
Discussing the roadmap to first-in-man melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans
Melioidosis Vaccine Symposium: Moving from animal models to man
26 February 2019
Discussing the roadmap to first-in-man melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans
Member Resources
Membership Benefits
Metabolic reprogramming of skin microenvironment for improved BCG vaccine efficacy
